Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Serum Level of Interleukin 12 in Patients With Multiple Sclerosis Publisher Pubmed



Jahanbaniardakani H1 ; Alsahebfosoul F2 ; Moshfeghi SR2 ; Mahaki B3 ; Etemadifar M4 ; Abtahi SH2 ; Fereidanesfahani M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Medical Students Research Center (IMSRC), Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Neurology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Neurology, Mayo Clinic, Rochester, NY, United States

Source: International Journal of Neuroscience Published:2019


Abstract

[No abstract available]
Related Docs
1. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
Experts (# of related papers)